The quarterly and annual financials of Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) released last Wednesday sent the company’s…
Tag: Teva
Teva CEO responds to 25% share price fall
Since publishing its financial results for 2024 at the end of January, the share price of Teva Pharmaceutical Industries…
Teva files to raise first capital since 2016
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has filed a shelf prospectus with the US Securities and Exchange…